Financials
Income statement
| Fiscal date | May 2025 | Feb 2025 | Nov 2024 | Aug 2024 |
|---|---|---|---|---|
| Total reported revenue | 0 | 0 | 0 | 0 |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | 1.8M | 320.3K | 308.7K | 214.7K |
| Selling general and admin | 1.1M | 2.2M | 2.1M | 1.7M |
| Other operating expenses | — | — | — | — |
| Operating income | -2.9M | -2.6M | -2.4M | -2.0M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | -1.9M | -1.0M | 16.6M | -156.9K |
| Pretax income | -4.8M | -3.6M | 14.2M | -2.1M |
| Tax provision | 0 | 0 | 0 | 0 |
| Net income | -4.8M | -3.6M | 14.2M | -2.1M |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | 14.4M | -1.5M | -18.9M | -1.8M |
| Net income from continuing op. | -4.8M | -3.6M | 14.2M | -2.1M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |